AU2001224718A1 - A medicinal aerosol formulation - Google Patents
A medicinal aerosol formulationInfo
- Publication number
- AU2001224718A1 AU2001224718A1 AU2001224718A AU2471801A AU2001224718A1 AU 2001224718 A1 AU2001224718 A1 AU 2001224718A1 AU 2001224718 A AU2001224718 A AU 2001224718A AU 2471801 A AU2471801 A AU 2471801A AU 2001224718 A1 AU2001224718 A1 AU 2001224718A1
- Authority
- AU
- Australia
- Prior art keywords
- aerosol formulation
- medicinal aerosol
- medicinal
- formulation
- aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20122900P | 2000-05-01 | 2000-05-01 | |
US60201229 | 2000-05-01 | ||
US09702201 | 2000-10-31 | ||
US09/702,201 US6548049B1 (en) | 2000-05-01 | 2000-10-31 | Medicinal aerosol formulation |
PCT/US2001/000035 WO2001082874A2 (en) | 2000-05-01 | 2001-01-02 | A medicinal aerosol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001224718A1 true AU2001224718A1 (en) | 2001-11-12 |
Family
ID=26896531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001224718A Abandoned AU2001224718A1 (en) | 2000-05-01 | 2001-01-02 | A medicinal aerosol formulation |
Country Status (3)
Country | Link |
---|---|
US (1) | US6548049B1 (en) |
AU (1) | AU2001224718A1 (en) |
WO (1) | WO2001082874A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
WO2003045383A1 (en) * | 2001-11-26 | 2003-06-05 | Arachnova Therapeutics Ltd. | Use of ppar activators for the treatment of pulmonary fibrosis |
AU2003230719A1 (en) * | 2002-03-21 | 2003-10-08 | Teva Pharmaceutical Industries Ltd. | Fine particle size pioglitazone |
US7655618B2 (en) | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
MXPA05006994A (en) | 2002-12-27 | 2005-10-18 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia. |
US7683029B2 (en) * | 2003-05-07 | 2010-03-23 | Philip Morris Usa Inc. | Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin |
US7299802B2 (en) * | 2003-06-17 | 2007-11-27 | Spencer Feldman | Carbon dioxide delivery apparatus and method for using same |
US7824436B2 (en) * | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US8721699B2 (en) | 2005-05-13 | 2014-05-13 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
WO2010054249A1 (en) * | 2008-11-07 | 2010-05-14 | Benechill, Inc. | Methods of nasopharyngeal cooling for augmenting coronary perfusion pressure |
WO2010148372A1 (en) | 2009-06-19 | 2010-12-23 | Benechill | Devices for cooling the nasal cavity |
TWI399202B (en) | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | The preparation for formulation composition and manufacturing processes of metered dose inhalers treated respiratory diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011678A (en) | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
JPH05508616A (en) | 1989-02-23 | 1993-12-02 | ローヌー プーラン ローラー インターナショナル(ホウルディングス)インコーポレイテッド | therapeutic aerosol |
US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
GB9202519D0 (en) | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
AU679511B2 (en) * | 1993-03-17 | 1997-07-03 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
WO1996019198A1 (en) | 1994-12-22 | 1996-06-27 | Astra Aktiebolag | Aerosol drug formulations |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US6193954B1 (en) | 1997-03-21 | 2001-02-27 | Abbott Laboratories | Formulations for pulmonary delivery of dopamine agonists |
-
2000
- 2000-10-31 US US09/702,201 patent/US6548049B1/en not_active Expired - Fee Related
-
2001
- 2001-01-02 WO PCT/US2001/000035 patent/WO2001082874A2/en active Application Filing
- 2001-01-02 AU AU2001224718A patent/AU2001224718A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6548049B1 (en) | 2003-04-15 |
WO2001082874A3 (en) | 2002-04-25 |
WO2001082874A2 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001224716A1 (en) | A medicinal aerosol formulation | |
AU2001226233A1 (en) | A medicinal aerosol formulation | |
AU2753001A (en) | A medicinal aerosol formulation | |
EP1296723A4 (en) | A medicinal aerosol formulation | |
AU4519001A (en) | A medicinal aerosol formulation | |
AU2002218250A1 (en) | Medicament dispenser | |
AU6310000A (en) | Aerosol formulations | |
AU1131102A (en) | Medicinal aerosol formulations | |
AU2002223562A1 (en) | Medicament dispenser | |
AUPR054400A0 (en) | A castor | |
AU2001227535A1 (en) | A core formulation | |
AU2001227532A1 (en) | A core formulation | |
AU2001224718A1 (en) | A medicinal aerosol formulation | |
AU2623401A (en) | A medicinal aerosol formulation | |
AUPR000900A0 (en) | A berley dispenser | |
AU2001259318A1 (en) | A medicinal aerosol formulation | |
AU1141101A (en) | Pharmaceutical aerosol formulations comprising s-salmeterol | |
HUP0600143A2 (en) | A stable pharmaceutical formulation comprising torsemide modification ii | |
AU2001247123A1 (en) | A medicinal aerosol formulation | |
AU2001227531A1 (en) | A medicinal aerosol formulation | |
EP1292283A4 (en) | A medicinal aerosol formulation | |
AU2001272718A1 (en) | Medicaments | |
AU2002215902A1 (en) | Medicament dispenser | |
GB0014849D0 (en) | Pharmaceutical aerosol formulation | |
AU2002223437A1 (en) | Medicament dispenser |